Some links on this page are affiliate links: if you buy through them we may earn a commission, at no extra cost to you.
Elon Musk did not say that every form of longer life is dangerous, nor did he argue that people should simply die. In a December 6, 2021 interview with The Wall Street Journal’s Joanna Stern, Musk discussed hypothetical indefinite life extension. His concern was that people who never died could keep outdated ideas, wealth and political power in place, leaving society “ossified” and making it harder for new generations to shape the future.
That is a social and political argument—not evidence that a particular immortality technology exists or that longevity medicine is inherently unsafe.
The comment was about a hypothetical future, not an available product
The headline refers to Musk’s appearance at the 2021 WSJ CEO Council Summit on December 6, 2021. Joanna Stern asked him about life extension and the possibility of technology that could combat aging.
Musk said he was not aware of secret technology capable of doing that. He then made a broader argument: people often do not substantially change their minds during their lifetimes, and if they lived indefinitely, older ideas could remain in control indefinitely. He described the result as a society becoming “ossified,” with new ideas struggling to succeed.
#1 Best Overall
He also connected the subject with population ageing and declining birth rates. In Musk’s view, longer lives could intensify demographic pressures if people lived much longer while having fewer children.
The contemporary coverage that produced the headline captured the provocative part of the exchange, but “Musk says people should die” would be an overstatement. His more precise position was that mortality may perform a generational-renewal function. He was not rejecting ordinary medical treatment, calling modest increases in healthy life dangerous, or presenting a scientific finding that death is necessary for innovation. The archived transcript provides the interview context.
It is also important to date the claim correctly. This was a 2021 discussion about a hypothetical future, not a new August 2026 announcement about a working immortality technology.
The Tool Desk
Outbyte Driver Updater FREEFix the driver behind crashes, sound loss and screen glitchesFind Drivers →Outbyte PC Repair FREEClear out junk files and repair common Windows errorsFree Scan →Immortality, lifespan and healthspan are not the same thing
“Immortality technology” is a media shorthand that collapses several very different ideas:
- Immortality would mean indefinite survival. Medicine has not achieved it.
- Lifespan extension means adding years to a person’s life, whether or not those years are lived in good health.
- Healthspan extension means preserving physical and cognitive function for more years, ideally reducing disability and age-related disease.
- Rejuvenation refers to attempts to restore biological function or reverse some age-related deterioration.
- Longevity medicine is a broad, loosely defined term covering preventive care, risk reduction, biomarker testing and experimental interventions.
Most serious biomedical work is aimed at delaying disease and preserving function—not guaranteeing endless life. Preventing a heart attack at 70, repairing damaged tissue, replacing an organ, slowing a particular disease and preserving a body after legal death are separate propositions. They should not be treated as stages of one established path to immortality.
What longevity medicine can actually do
As of August 18, 2026, no treatment has been established as a way to make humans immortal or reliably reverse the entire ageing process. The U.S. Food and Drug Administration has not approved a drug specifically to treat human ageing itself; ageing is not classified by the FDA as a disease in the ordinary drug-approval framework, as discussed in this Wall Street Journal discussion.
That does not mean longevity research is empty. It means the evidence must be described at the level it supports.
Do these 3 things before closing this tab:
1Repair Windows errors before they cause bigger problems2Scan for outdated or missing drivers - takes under a minute3Clear out junk files and repair common Windows errorsEstablished ways to improve healthy longevity
The strongest evidence for living longer and healthier generally comes from conventional medicine and public-health measures:
Rank #2
- Author: Piers Anthony. | Publisher: Del Rey| Pages: 336| Publication Date: 1986-09-12| Edition: Incarnations of Immortality Bk. 1| Binding: Mass Market Paperback| MSRP: 7.99| ISBN13: 9780345338587| ISBN: 0345338588| Other ISBN: 9780307815651| Other ISBN Binding: printisbn| Language: en| Store Location: Sci Fi|"Book cover image may be different than what appears on the actual book."
- vaccination and infection prevention;
- treatment of high blood pressure and high cholesterol;
- smoking cessation;
- regular aerobic activity, resistance training and fall prevention;
- adequate sleep and a sustainable diet;
- screening and treatment for cancers where screening is recommended;
- management of diabetes and cardiovascular risk; and
- timely diagnosis and treatment of existing disease.
These measures are less dramatic than a promise of age reversal, but they have a much clearer connection to preventing disability and premature death than most products marketed specifically as anti-ageing solutions.
Experimental approaches
Researchers are studying senolytics, rapamycin and related drugs, metformin-related interventions, cellular reprogramming, stem-cell and tissue-repair approaches, gene therapies, immune-system rejuvenation, regenerative medicine and biomarker-guided prevention.
These categories have different mechanisms, evidence and safety questions. Positive results in cells, worms or mice do not establish that a treatment extends healthy life in humans. A clinical trial shows that a question is being studied; it does not show that the intervention works. An intervention may help a patient with a specific disease without extending life in healthy people.
What’s actually slowing this PC down?
Pick the symptom - the matching free tool is one click away.
Industry coverage of longevity research describes companies testing preventative or age-related interventions, but those efforts should not be confused with a proven immortality treatment.
Is Musk’s fear of social stagnation plausible?
Yes—as a governance concern. No—as a demonstrated biological law.
Musk’s argument identifies several mechanisms through which indefinite life could create institutional lock-in:
- A political leader, chief executive or major owner could remain in place for centuries.
- Wealth and property could compound across an unusually long lifetime.
- Younger people could face fewer jobs, leadership positions, homes and opportunities to accumulate assets.
- Institutions might resist disruptive ideas because the people who built them never leave.
- Succession, inheritance and cultural turnover could slow down.
- People who gained influence under earlier conditions could continue shaping rules long after those conditions changed.
Those are credible questions, particularly if life extension were expensive and available first to people who already possess wealth and influence. The central social risk might not be that older minds inevitably reject new ideas. It might be that the same small group retains ownership, office and agenda-setting power for much longer.
But the conclusion does not follow automatically. People can change their minds without dying. Retirement rules, term limits, succession planning, anti-monopoly enforcement, inheritance taxation, broader education and democratic participation could encourage turnover without requiring biological death. A person whose tissues are rejuvenated may also differ substantially from a frail elderly person in health, motivation and capacity.
Rank #3
Whether longer lives produce stagnation would depend on institutions, access and rules—not simply on the number of years a body remains alive.
The demographic question is more complicated than “more life equals fewer births”
Musk has long expressed concern about declining birth rates, and he linked that concern to longevity. But the demographic effects of life extension are not one-directional.
Several scenarios are possible:
- Longer lives with unchanged fertility: populations could grow unless births or migration changed elsewhere.
- Longer lives with delayed or reduced fertility: the population could age, with a larger old-to-young ratio and fewer births per generation.
- Longer healthy working lives: people might work, care for relatives and contribute economically for more years, reducing some retirement pressure.
- Longer lives with sustained fertility: housing, education, healthcare and other resources could face greater demand.
The actual result would depend on fertility, migration, retirement patterns, healthcare costs, productivity, access to treatment and the extent to which healthspan rises along with lifespan. It is not accurate to claim that life extension automatically causes population collapse or that it necessarily produces a population crisis.
The strongest case against Musk’s conclusion
There is a powerful humanitarian argument for extending healthy life. Age-related disease causes suffering, disability and loss of independence. Keeping people healthy for longer could allow them to remain active in families, workplaces and communities. More healthy years could also mean more time for scientific research, artistic work, caregiving, education and cooperation between generations.
That is not the same goal as making a person invulnerable or immortal. A therapy that delays dementia, prevents cardiovascular disease or maintains mobility could provide major benefits even if it adds no centuries to a life.
It is also possible that experience is an asset rather than an obstacle. Scientists, doctors, engineers and public servants may produce better work when they have more time to learn and apply knowledge. A society with longer healthy lives might retain expertise that is currently lost through preventable decline.
The argument for healthspan extension therefore cannot be dismissed merely because indefinite survival raises difficult questions. The relevant comparison is often not “immortality versus death,” but “more years of capable life versus years of disease and dependency.”
Free tools Windows power users keep installed
One-click scans. No signup required.
The strongest case for Musk’s concern
The case becomes stronger when “longer life” is combined with unequal access and weak governance.
Rank #4
- Great extension activities for science and biology
- Correlated to standards
- Comprehensive biology vocabulary study
- Fascinating true-to-life illustrations
If only wealthy people could afford effective rejuvenation, they could retain businesses, land, political influence and investment assets for far longer than everyone else. Their heirs might wait longer for transfers of wealth, while younger workers could compete against people with centuries of accumulated capital and networks.
High-end longevity services already illustrate the access problem, even though they do not provide immortality. Recent reporting has described some memberships as costing six figures a year, with prices as high as $250,000 annually at the extreme high end. That figure is a reported market example, not a standard price, and it does not demonstrate that the services improve lifespan. It does show why access and evidence matter when longevity care is sold as a premium product. See the Wall Street Journal report.
The policy questions would include:
- Who receives a proven treatment first?
- Would public health systems cover it?
- Would employers expect people to work indefinitely?
- How would pensions, inheritance and housing markets change?
- What limits would apply to political office and corporate control?
- Could a person’s extended life become extended domination over other people?
These are not arguments against researching healthspan. They are arguments for treating longevity as a governance issue as well as a medical one.
Quick wins for a faster PC:
Scan for outdated or missing drivers - takes under a minuteDriver Scan →Repair Windows errors before they cause bigger problemsFix Now →“Dangerous” can mean several different things
Musk primarily discussed social stagnation, population ageing and generational turnover. He did not offer a comprehensive medical risk assessment of anti-ageing biology. A complete discussion would separate at least five kinds of danger:
- Medical risk: experimental therapies may cause immune reactions, infections, cancer, organ damage or other adverse effects.
- Opportunity cost: people may spend money on unproven protocols while neglecting blood-pressure treatment, vaccinations, exercise or recommended screening.
- Inequality: scarce and expensive treatments could allow wealthy people to preserve health, assets and influence for much longer.
- Institutional lock-in: leaders, owners and policymakers could remain in influential positions indefinitely.
- Demographic disruption: retirement, pensions, housing, education, labour markets and family structures could all be transformed.
A headline that says immortality technology is “dangerous” may therefore be pointing at a real category of risk, but it does not tell readers which risk is meant. Musk’s warning was mainly about the fourth and fifth categories.
Independent reader supportYour contribution helps us test, update, and keep practical guides available for everyone.Consumer longevity products need careful scrutiny
The commercial market includes biological-age and epigenetic tests, wearables, continuous glucose monitors, executive-health programs, longevity clinics, supplements and cryonics. Their usefulness varies widely.
A biomarker score is not equivalent to a validated prediction of remaining lifespan. A lower “biological age” result does not prove slower ageing or longer survival. “FDA registered,” “FDA listed” or “made with FDA-approved ingredients” does not mean that a product is FDA-approved to treat ageing.
Before paying for a longevity service or joining an experimental program, ask:
Best Value
- Students build unmatched deductive-reasoning skills as they become crime-solving stars
- Most scenarios have more than one plausible outcome, allowing individuals or groups to broadly interpret evidence
- Includes interpretive handwriting, body language, fingerprinting, and many more activities
- Is the intervention approved for the purpose being advertised?
- Is the evidence from humans, or only from cells or animals?
- Does it improve lifespan, healthspan or only one biomarker?
- Was the study randomized, controlled and large enough to support the claim?
- What adverse effects and drug interactions are known?
- Is the service regulated as a drug, device, laboratory test, supplement or wellness program?
- Does the provider clearly separate research from treatment?
- Could the service delay diagnosis or replace proven medical care?
- Are the outcomes meaningful to patients rather than merely impressive on a dashboard?
- Are recurring costs, cancellation terms and follow-up expenses clear?
Supplements can interact with medicines and cause toxicity despite being marketed as natural. A wealthy person’s access to an experimental protocol does not demonstrate that the protocol is safe or effective.
Clinical trials and cryonics
ClinicalTrials.gov is a useful starting point for finding legitimate research, but eligibility and risk vary by study. Registration is not proof of efficacy, and participation should involve an appropriate discussion of risks with qualified clinicians.
Alcor and Tomorrow Bio offer cryonics-related preservation services. Cryonics takes place after legal death and preserves tissue in the hope that future technology might enable repair or revival. It is not demonstrated revival technology and should not be described as current immortality.
Recommended Free Tools
What would responsible longevity policy look like?
If therapies eventually prove capable of extending healthy life, societies would not have to choose between unrestricted immortality and banning the research. They could address Musk’s concerns through institutional design.
- Require strong human evidence and transparent adverse-event reporting.
- Separate approved treatment from experimental care and wellness marketing.
- Use term limits, retirement rules or succession requirements where appropriate.
- Prevent monopolies and excessive concentration of ownership.
- Review inheritance and estate rules if lifetimes and wealth accumulation change substantially.
- Expand access to proven preventive care instead of subsidizing unvalidated claims.
- Protect younger generations’ access to education, housing, employment and political representation.
- Measure healthspan and functional independence, not just survival or biological-age scores.
Such rules would recognize that a longer-lived society might need new forms of turnover and accountability. They would also preserve the benefits of preventing avoidable disease.
Bottom line
Elon Musk’s 2021 warning was not proof that immortality technology exists, and it was not a blanket rejection of medical progress. He argued that indefinite life could preserve outdated ideas, concentrate power and worsen demographic pressures. That is a serious political and ethical question, but it is not an established scientific consequence of longevity medicine.
The technology available today is far more limited: established preventive care can reduce disease risk, while rejuvenation, senolytics, gene therapies and other longevity approaches remain research areas with uneven evidence. The useful debate is not whether people should die. It is whether society can safely extend healthy life while preventing unequal access, medical hype and prolonged control by a small group of people.
Windows Errors? Fix Them Before They Spread
Repair common Windows errors and clear accumulated junk for a smoother, more stable PC - no reinstall needed.Free scan · no reinstallOutdated Drivers Are Slowing You Down
One free scan finds every outdated or missing driver and matches the right update for your exact hardware.Free scan · exact hardware matchQuick Recap
Product prices and availability are accurate as of the date/time indicated and are subject to change. Any price and availability information displayed on Amazon at the time of purchase will apply.
